Follow
John Asplin
John Asplin
litholink corporation
Verified email at labcorp.com
Title
Cited by
Cited by
Year
The pathogenesis and treatment of kidney stones
FL Coe, JH Parks, JR Asplin
New England Journal of Medicine 327 (16), 1141-1152, 1992
10141992
Effects of phosphate binders in moderate CKD
GA Block, DC Wheeler, MS Persky, B Kestenbaum, M Ketteler, ...
Journal of the American Society of Nephrology 23 (8), 1407-1415, 2012
6672012
Vegetarian compared with meat dietary protein source and phosphorus homeostasis in chronic kidney disease
SM Moe, MP Zidehsarai, MA Chambers, LA Jackman, JS Radcliffe, ...
Clinical Journal of the American Society of Nephrology 6 (2), 257-264, 2011
6302011
Calcium oxalate urolithiasis in mice lacking anion transporter Slc26a6
Z Jiang, JR Asplin, AP Evan, VM Rajendran, H Velazquez, TP Nottoli, ...
Nature genetics 38 (4), 474-478, 2006
3472006
The contribution of malabsorption to the reduction in net energy absorption after long-limb Roux-en-Y gastric bypass
EA Odstrcil, JG Martinez, CA Santa Ana, B Xue, RE Schneider, KJ Steffer, ...
The American journal of clinical nutrition 92 (4), 704-713, 2010
2522010
NALP3-mediated inflammation is a principal cause of progressive renal failure in oxalate nephropathy
F Knauf, JR Asplin, I Granja, IM Schmidt, GW Moeckel, RJ David, ...
Kidney international 84 (5), 895-901, 2013
2442013
Hyperoxaluria in kidney stone formers treated with modern bariatric surgery
JR Asplin, FL Coe
The Journal of urology 177 (2), 565-569, 2007
2162007
Molecular modifiers reveal a mechanism of pathological crystal growth inhibition
J Chung, I Granja, MG Taylor, G Mpourmpakis, JR Asplin, JD Rimer
Nature 536 (7617), 446-450, 2016
2142016
Hyperoxaluric calcium nephrolithiasis
JR Asplin
Endocrinology and Metabolism Clinics 31 (4), 927-949, 2002
2102002
Nephrolithiasis
JR Asplin
Nephrology Secrets, 123-130, 2012
2072012
A single 24-hour urine collection is inadequate for the medical evaluation of nephrolithiasis
JH Parks, E Goldfisher, JR Asplin, FL Coe
The Journal of urology 167 (4), 1607-1612, 2002
1842002
Evidence of calcium phosphate supersaturation in the loop of Henle
JR Asplin, NS Mandel, FL Coe
American Journal of Physiology-Renal Physiology 270 (4), F604-F613, 1996
1831996
Contribution of human uropontin to inhibition of calcium oxalate crystallization
JR Asplin, D Arsenault, JH Parks, FL Coe, JR Hoyer
Kidney international 53 (1), 194-199, 1998
1821998
Phosphorylated osteopontin peptides suppress crystallization by inhibiting the growth of calcium oxalate crystals
JR Hoyer, JR Asplin, L Otvos Jr
Kidney international 60 (1), 77-82, 2001
1612001
Uric acid stones.
JR Asplin
Seminars in nephrology 16 (5), 412-424, 1996
1581996
Obesity and urolithiasis
JR Asplin
Advances in chronic kidney disease 16 (1), 11-20, 2009
1472009
Calcium oxalate stone formation in genetic hypercalciuric stone-forming rats
DA Bushinsky, JR Asplin, MD Grynpas, AP Evan, WR Parker, ...
Kidney international 61 (3), 975-987, 2002
1412002
Specificity of growth inhibitors and their cooperative effects in calcium oxalate monohydrate crystallization
S Farmanesh, S Ramamoorthy, J Chung, JR Asplin, P Karande, JD Rimer
Journal of the American Chemical Society 136 (1), 367-376, 2014
1392014
Effect of grapefruit juice on urinary lithogenicity
DS GOLDFARB, JR ASPLIN
The Journal of urology 166 (1), 263-267, 2001
1332001
Bone mineral density and urine calcium excretion among subjects with and without nephrolithiasis
JR Asplin, KA Bauer, J Kinder, G Müller, BJ Coe, JH Parks, FL Coe
Kidney international 63 (2), 662-669, 2003
1302003
The system can't perform the operation now. Try again later.
Articles 1–20